Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DO76YM
|
|||
| Drug Name |
AGTC-501
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Retinitis pigmentosa [ICD-11: 9B70; ICD-10: H35.5] | Phase 1/2 | [1] | |
| Company |
Applied Genetic Technologies
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | X-linked retinitis pigmentosa GTPase regulator (RPGR) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03316560) Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.